ADAGENE INC-ADR (ADAG) Stock Overview
NASDAQ:ADAG - US0053291078 - ADR
ADAG Key Statistics, Chart & Performance
The current stock price of ADAG is 2.13 USD. In the past month the price increased by 10.94%. In the past year, price decreased by -23.93%.
ADAG Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.87 | 371.68B | ||
| AMGN | AMGEN INC | 13.19 | 154.89B | ||
| GILD | GILEAD SCIENCES INC | 14.6 | 140.17B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.08 | 100.25B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.72 | 61.55B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 58.53B | ||
| ARGX | ARGENX SE - ADR | 76.83 | 43.59B | ||
| ONC | BEONE MEDICINES LTD-ADR | 6.16 | 36.38B | ||
| INSM | INSMED INC | N/A | 28.77B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.04B | ||
| NTRA | NATERA INC | N/A | 23.09B | ||
| BIIB | BIOGEN INC | 8.26 | 19.38B |
Related stock screener links
About ADAG
Company Profile
Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. The company is headquartered in Suzhou, Jiangsu and currently employs 138 full-time employees. The company went IPO on 2021-02-09. The firm is principally engaged in the research, development and production of monoclonal antibody drugs for cancers. The Company’s main products include: ADG106 is being developed for the treatment of advanced solid tumors and non-Hodgkin's lymphoma, or NHL. ADG126 is designed to address the toxicity and efficacy issues related to the MOA of existing approved CTLA-4 immuno-oncology therapies and to expand the potential of CTLA-4 as a target for the treatment of cancer. ADG116 is designed to target a unique conserved epitope of CTLA-4. And ADG104, a monospecific antibody that targets PD-L1 and is in Phase Ib and Phase II clinical trials concurrently in China.
Company Info
ADAGENE INC-ADR
4F, Building C14, No. 218, Xinghu Street, Suzhou Industrial Park
Suzhou JIANGSU 215123 CN
CEO: Peter (Peizhi) Luo
Employees: 138
Phone: 8651287773632
ADAGENE INC-ADR / ADAG FAQ
What is the stock price of ADAGENE INC-ADR today?
The current stock price of ADAG is 2.13 USD. The price decreased by -4.05% in the last trading session.
What is the ticker symbol for ADAGENE INC-ADR stock?
The exchange symbol of ADAGENE INC-ADR is ADAG and it is listed on the Nasdaq exchange.
On which exchange is ADAG stock listed?
ADAG stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ADAGENE INC-ADR stock?
10 analysts have analysed ADAG and the average price target is 9.84 USD. This implies a price increase of 361.75% is expected in the next year compared to the current price of 2.13. Check the ADAGENE INC-ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ADAGENE INC-ADR worth?
ADAGENE INC-ADR (ADAG) has a market capitalization of 100.34M USD. This makes ADAG a Micro Cap stock.
How many employees does ADAGENE INC-ADR have?
ADAGENE INC-ADR (ADAG) currently has 138 employees.
What are the support and resistance levels for ADAGENE INC-ADR (ADAG) stock?
ADAGENE INC-ADR (ADAG) has a support level at 2.12 and a resistance level at 2.37. Check the full technical report for a detailed analysis of ADAG support and resistance levels.
Is ADAGENE INC-ADR (ADAG) expected to grow?
The Revenue of ADAGENE INC-ADR (ADAG) is expected to grow by 8.17% in the next year. Check the estimates tab for more information on the ADAG EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ADAGENE INC-ADR (ADAG) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ADAG, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ADAG, evaluating the profitability, health, valuation and growth aspects
- ADAGENE INC-ADR (ADAG) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ADAGENE INC-ADR (ADAG) Sales and EPS estimates to see what analysts future expectations are.
- ADAGENE INC-ADR (ADAG) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ADAGENE INC-ADR (ADAG) Insider and Institutional Ownership to learn about the owners and their transactions.
- ADAGENE INC-ADR (ADAG) Stock Chart to make your own analysis
- ADAGENE INC-ADR (ADAG) Latest news and press-releases to stay up to date.
Does ADAGENE INC-ADR (ADAG) stock pay dividends?
ADAG does not pay a dividend.
What is the Price/Earnings (PE) ratio of ADAGENE INC-ADR (ADAG)?
ADAGENE INC-ADR (ADAG) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.72).
What is the Short Interest ratio of ADAGENE INC-ADR (ADAG) stock?
The outstanding short interest for ADAGENE INC-ADR (ADAG) is 0.17% of its float. Check the ownership tab for more information on the ADAG short interest.
ADAG Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to ADAG. When comparing the yearly performance of all stocks, ADAG is a bad performer in the overall market: 81.12% of all stocks are doing better.
ADAG Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ADAG. ADAG may be in some trouble as it scores bad on both profitability and health.
ADAG Financial Highlights
Over the last trailing twelve months ADAG reported a non-GAAP Earnings per Share(EPS) of -0.72. The EPS decreased by -71.88% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -37.44% | ||
| ROE | -66.16% | ||
| Debt/Equity | 0.1 |
ADAG Forecast & Estimates
10 analysts have analysed ADAG and the average price target is 9.84 USD. This implies a price increase of 361.75% is expected in the next year compared to the current price of 2.13.
For the next year, analysts expect an EPS growth of -1.9% and a revenue growth 8.17% for ADAG